The Biopharma CEO Confidence Index is a forward-looking indicator designed to measure C-suite sentiment and confidence in the biopharma industry’s economy.  Click below to view current and past results.

This confidence—or lack thereof—is defined by the degree of optimism within key business indicators.  Measuring confidence through these six indicators over time will demonstrate an ebb and flow of market dynamics and confidence in the future success of companies and growth in the overall market.

  • Capital Markets
  • Deal Landscape
  • Clinical Development
  • Regulatory Affairs
  • Commercialization
  • Business Model and Workforce